Editor-in-Chief: Siest, Gérard
Editorial Board Member: Chen, Bing / Devinsky, Ferdinand / Henney, Adriano / Hirata, Rosario D. C. / Ingelman-Sundberg, Magnus / Llerena, Adrián / Manolopoulos, Vangelis G. / Meyer, Urs A. / Patrinos, George / Schaik, Ron / Sadee, Wolfgang / Turpeinen, Miia / Maitland-van de Zee, Anke-Hilse / Zanger, Ulrich M. / Marc, Janja / Hubacek, Jaroslav A.
4 Issues per year
Volume 27 (2012)
Volume 26 (2011)
Volume 25 (2010)
Volume 22 (2007)
Volume 21 (2006)
Volume 20 (2004)
Volume 19 (2003)
Volume 18 (2001)
Volume 16 (2000)
Volume 17 (2000)
Volume 15 (1999)
Volume 14 (1998)
Volume 13 (1997)
Volume 12 (1995)
Volume 11 (1994)
Volume 10 (1992)
Volume 9 (1991)
Volume 8 (1990)
Volume 5 (1987)
Volume 4 (1982)
Most Downloaded Articles
- 6th Santorini Conference Biologie Prospective 2012
- The aryl hydrocarbon receptor system by Barouki, Robert/ Aggerbeck, Martine/ Aggerbeck, Lawrence and Coumoul, Xavier
- European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies: the 2012 Declaration of Rome by Brand, Angela and Lal, Jonathan A.
- Public Health Genomics and Personalized Healthcare: a pipeline from cell to society by Brand, Angela
- Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes by Zhou, Xuelin/ Chan, Kelvin and Yeung, John H.K.
Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects
1Department of Pharmacy, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China
aCurrent address: Department of Clinical Pharmacology, Jinling Hospital, 305 East Zhongshan Road, Nanjing 210002, P.R. China
Citation Information: Drug Metabolism and Drug Interactions. Volume 26, Issue 3, Pages 113–118, ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: 10.1515/DMDI.2011.016, October 2011
- Published Online:
Background: The aim of this study was to elucidate the gene dose effect of NAT2 and the effect on the pharmacokinetics of isoniazid (INH) and its metabolites acetylisoniazid (AcINH) in Chinese subjects.
Methods: A total of 24 healthy Chinese subjects, consisting of eight homozygous wild types (wt/wt), eight heterozygous mutants (m/wt) and eight homozygous mutants (m/m) for NAT2, were enrolled in the study. The blood samples (0–14 h) of the subjects were taken after oral administration of a single dose (300 mg) of INH. Concentrations of INH and AcINH in plasma were measured by a reversed-phase HPLC method.
Results: The ratio of AcINH and INH (RA/I) 3 h post-dose of wt/wt, m/wt and m/m groups were 3.22±1.34, 1.35±0.20 and 0.22±0.06, respectively (p<0.01). The area under concentration-time curve (AUC) values of three groups were 10.35±2.12, 16.34±3.05, 42.24±8.51 mg/h/L for INH and 42.19±8.80, 38.05±5.32, 19.78±3.72 mg/h/L for AcINH, respectively (p<0.01). There was a good linear relationship between pharmacokinetic parameters and the number of active NAT2 genes.
Conclusions: The results suggest that there is a conspicuous gene dose effect in the pharmacokinetics of INH and AcINH. This finding may be valuable in the personalized therapy of tuberculosis with INH.